✦ LIBER ✦

Pharmacokinetics of cyclosporine in heart transplant recipients receiving metabolic inhibitors

✍ Scribed by Fatemeh Akhlaghi; Anne M Keogh; Andrew J McLachlan; Annemarie Kaan

Book ID: 117709044
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 222 KB
Volume: 20
Category: Article
ISSN: 1557-3117
DOI: 10.1016/s1053-2498(00)00234-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population Pharmacokinetics of Cyclospor

Population Pharmacokinetics of Cyclosporine in Transplant Recipients

✍ Kelong Han, Venkateswaran C. Pillai, Raman Venkataramanan 📂 Article 📅 2013 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 300 KB

Decision Support Tool to Individualize C

Decision Support Tool to Individualize Cyclosporine Dose in Stable, Long-term Heart Transplant Recipients Receiving Metabolic Inhibitors: Overcoming Limitations of Cyclosporine C2 Monitoring

✍ John E. Ray; Anne M. Keogh; Andrew J. McLachlan 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 203 KB

A study of craniofacial growth in infant

A study of craniofacial growth in infant heart transplant recipients receiving cyclosporine

✍ David G Niles; R.David Rynearson; Marti Baum; Roland D.W Neufeld; Joseph M Carus 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 307 KB

Limited utility of cyclosporine C2 monit

Limited utility of cyclosporine C2 monitoring in heart transplant recipients receiving ketoconazole

✍ M Zakliczynski; A Krynicka; M Szewczyk; J Wojarski; M Zembala 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Cyclosporin pharmacokinetics in heart-lu

Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis

✍ V. T. Tsang; A. Johnston; F. Heritier; N. Leaver; M. E. Hodson; M. Yacoub 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 529 KB

Cyclosporin (CsA) is currently the main immunosuppressive agent used in organ transplantation with considerable improvement in graft survival. Oral CsA solution is highly lipophilic, and its bioavailability may be reduced in cystic fibrosis (CF) heart-lung transplant recipients with pancreatic, gas

Cyclosporin C2 and C0 concentration moni

Cyclosporin C2 and C0 concentration monitoring in stable, long-term heart transplant recipients receiving metabolic inhibitors

✍ John E Ray; Anne M Keogh; Andrew J McLachlan; Fatemah Akhlaghi 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 146 KB